All the latest Bit Zesty news, straight from the team.
Whilst we were upgrading our web applications to meet the Web Content Accessibility Guidelines (WCAG) 2.1, we noticed that the javascript library we were using to enhance the behaviour of some select boxes was not fully accessible.
After someone unexpectedly turned up for a job interview at our London office that was closed at the time due to COVID-19, we realised Bit Zesty was a victim of an elaborate impersonation by hackers who placed fake job adverts in our name. Scams and…
With the latest developments of Covid-19 across the world, remote working has become a new normal rather than a cultural choice for organisations.
Over the last few weeks, Bit Zesty has been working flat-out with SXT, a Community Interest Company (CIC) to develop a crucial contact tracing tool to speed up the ability to trace contacts of patients diagnosed with Covid-19. SXT previously engaged Bit Zesty to create…
Bit Zesty worked with Bridges to develop the first pilot web and mobile apps for people with Neuromuscular Diseases
As we enter a new decade, our in-house agency experts look ahead to anticipate how the technology trends, shifts in user experience and design, and ways of working will define how digital services will develop and how organisations will change in the coming years. Laura…
The rise of inclusive design is putting accessibility at the heart of new laws and legal precedents – and the most successful digital products and services. Accessibility still seems to be one of the biggest buzzwords in the industry. Every industry conference and awards event…
Bit Zesty won two awards at this year’s UXUK Awards! Our SXT digital partner notification tool won in both the Best Public Sector and Best Innovation categories at an awards ceremony in London. The User Experience UK (UXUK) Awards were established in 2013 to recognise…
The think tank for drug-resistant infections, SEDRIC, launched its new brand identity and website created by Bit Zesty this month. SEDRIC is The Surveillance and Epidemiology of Drug-resistant Infections Consortium. Funded by research charity Wellcome, the think tank brings together global experts